Breaking News

Close

Gilead Sciences Inc (GGILD)

	Symbol	Exchange	Currency
	GILD	NASDAQ	USD	Real-time
	GILD	Mexico	MXN	Delayed
	GGILD	Milan	EUR	Real-time
	GILD	Xetra	EUR	Delayed
	GILD	Frankfurt	EUR	Delayed
	GILD	TradeGate	EUR	Delayed
	GILD	Buenos Aires	ARS	Delayed
	GILD	Vienna	EUR	Real-time
	GILD	Lima	USD	Delayed

Add to/Remove from a Portfolio Add to Watchlist

70.90 -1.10 -1.53%

14:31:31 - Real-time Data. Currency in EUR ( Disclaimer )

Volume: 106
Bid/Ask: 70.72 / 71.04
Day's Range: 70.90 - 71.50

Type: Equity

Market: Italy

ISIN: US3755581036

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Comment
Financials
Technical
Forum

GGILD Balance Sheet

Assess the latest Gilead balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Annual Quarterly

InvestingPro

Advanced Balance Sheet

Period Ending:

2023

30/06

2023

31/03

2022

31/12

2022

30/09

Total Current Assets

15411

13456

14443

13554

Cash and Short Term Investments	8001	6266	6858	6238
Cash	-	-	-	-
Cash & Equivalents	8001	4936	5412	4699
Short Term Investments	-	1330	1446	1539
Total Receivables, Net	4229	4162	4777	4354
Accounts Receivables - Trade, Net	4229	4162	4777	4354
Total Inventory	3181	1576	1507	1463
Prepaid Expenses	-	1421	1241	1274
Other Current Assets, Total	-	31	60	225

Total Assets

62337

61876

63171

62557

Property/Plant/Equipment, Total - Net	5540	5479	5980	5349
Property/Plant/Equipment, Total - Gross	-	-	8166	-
Accumulated Depreciation, Total	-	-	-2186	-
Goodwill, Net	8314	8314	8314	8314
Intangibles, Net	27750	28348	28894	29440
Long Term Investments	-	2642	2611	2596
Note Receivable - Long Term	-	-	-	-
Other Long Term Assets, Total	5322	3637	2929	3304
Other Assets, Total	-1048	-1225	-1764	-1127

Total Current Liabilities

13964

10528

11237

10423

Accounts Payable	-	627	905	614
Payable/Accrued	-	-	-	-
Accrued Expenses	-	4184	6534	6245
Notes Payable/Short Term Debt	-	-	-	-
Current Port. of LT Debt/Capital Leases	-	2283	2384	2270
Other Current liabilities, Total	13964	3434	1414	1294

Total Liabilities

41243

40937

41962

41500

Total Long Term Debt	-	22956	22957	22953
Long Term Debt	-	22956	22957	22953
Capital Lease Obligations	-	-	-	-
Deferred Income Tax	-	2401	2673	3036
Minority Interest	-	-58	-31	-24
Other Liabilities, Total	27279	5110	5126	5112

Total Equity

21094

20939

21209

21057

Redeemable Preferred Stock, Total	-	-	-	-
Preferred Stock - Non Redeemable, Net	-	-	-	-
Common Stock, Total	21094	1	1	1
Additional Paid-In Capital	-	5793	5550	5226
Retained Earnings (Accumulated Deficit)	-	15223	15687	15756
Treasury Stock - Common	-	-	-	-
ESOP Debt Guarantee	-	-	-	-
Unrealized Gain (Loss)	-	-	-	-
Other Equity, Total	-	-78	-29	74

Total Liabilities & Shareholders' Equity

62337

61876

63171

62557

Total Common Shares Outstanding

1247

1248

1247

1254

Total Preferred Shares Outstanding

-

-

-

-

* In Millions of USD (except for per share items)

InvestingPro

Go to Dashboard InvestingPro

InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com UK's comment guidelines and agree to the terms described.

GILD Comments

Write your thoughts about Gilead Sciences Inc

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Oc Masai Apr 27, 2021 7:54

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Good job GILD. bullish move forward

0 0

Ashraf Elgendy Mar 07, 2021 13:03

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...

2 1

RM RM Mar 01, 2021 21:53

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Up Again

1 0

Ken Laing Oct 23, 2020 18:43

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Time to load up before the big rise coming next week

3 3

Iggy Maldon Jul 30, 2020 20:22

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Classic pump n’ dump. What a shambles

5 1

RM RM May 28, 2020 22:24

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Will reach above 95

10 5

Chili Daug May 28, 2020 22:24

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

when? hahah

0 0

SAGAR AGARWAL May 15, 2020 14:52

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Good time to accumulate.

4 1

Khizer Malik May 14, 2020 11:04

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr

8 2

Willy Chin Apr 23, 2020 18:14

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

High chance to be trading above 90, good long stock

9 4

Viktor Veselý Apr 12, 2020 7:48

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.

4 3

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="204313794">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="204313794" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="204313794" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="204313794">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200889478">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="200889478" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200889478" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d51-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d51-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200889478">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	FTSE 100	7,514.92	-93.16	-1.22%
	DAX	15,250.95	-135.63	-0.88%
	Euro Stoxx 50	4,140.05	-34.61	-0.83%
	S&P 500	4,297.83	+9.78	+0.23%
	Nikkei 225	31,793.50	-68.00	-0.21%
	Dow Jones	33,496.74	-10.76	-0.03%
	FTSE 100 Futures	7,557.0	-73.8	-0.97%

	Brent Oil	90.95	-1.25	-1.36%
	Crude Oil WTI	89.14	-1.65	-1.82%
	Gold	1,850.15	-15.95	-0.85%
	Silver	21.512	-0.938	-4.18%
	Copper	3.6513	-0.0862	-2.31%
	London Cocoa	3,024.00	+75.00	+2.54%
	London Wheat	186.10	-4.25	-2.23%

	U.K. 10Y	4.6080	+0.1660	+3.74%
	U.K. 5Y	4.6535	+0.1405	+3.11%
	U.K. 2Y	5.0260	+0.1220	+2.49%
	Germany 10Y	2.9160	+0.0050	+0.17%
	U.S. 10Y	4.681	+0.105	+2.30%
	U.S. 5Y	4.701	+0.097	+2.11%
	U.S. 2Y	5.108	+0.062	+1.23%

	Lloyds Banking	44.13	-1.04	-2.34%
	Vodafone Group PLC	76.56	-0.26	-0.34%
	Barclays	155.88	-3.06	-1.93%
	BT Group	115.60	-1.05	-0.90%
	HSBC	638.70	-6.20	-0.96%
	BHP Group Ltd	2,303.50	-36.00	-1.54%
	Exxon Mobil	115.39	-2.19	-1.86%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GGILD	70.90	-1.10	-1.53%

	Name	Last	Chg. %	Vol.
	Glencore	462.20	-1.64%	17.09M
	BP	519.10	-2.31%	14.24M
	Shell	2,587.0	-0.73%	6.22M
	British American Tobacco	2,535.5	-1.61%	3.29M
	Unilever	4,025.5	-0.90%	2.65M
	Rio Tinto PLC	5,111.0	-1.24%	1.25M
	AstraZeneca	10,944.0	-1.42%	804.66K

	Name	Last	Chg. %	Vol.
	TCS Group Holding PLC	19.50	+510.71%	30.00K
	Frontline	201.05	+77.45%	1.52K
	Zanaga	9.00	+60.68%	6.87M
	Clean Invest Africa	0.22	+50.00%	909.44K
	Dukemount	0.20	+38.46%	43.40M
	Valirx	8.0000	+34.19%	3.19M
	SAF Holland	6.70	0.00%	2.01K

	Name	Last	Chg. %	Vol.
	BioGaia B	101.60	-80.29%	3.30K
	H Lundbeck B	37.56	-78.38%	17.87K
	Tomra Systems	117.65	-66.17%	362.57K
	Atlas Copco B	128.35	-66.03%	62.11K
	Wirecard	0.69	0.00%	2.80K
	Rallye	1.51	0.00%	5.65K
	AMS	20.60	0.00%	0.90K